Chen H - Search Results

1

Correction to: Dynamic serum biomarkers to predict the efficacy of PD-1 in patients with nasopharyngeal carcinoma.

Zhang A, Zhong G, Wang L, Cai R, Han R, Xu C, Chen S, Sun P, Chen H. Zhang A, et al. Among authors: chen s, chen h. Cancer Cell Int. 2021 Dec 2;21(1):642. doi: 10.1186/s12935-021-02369-x. Cancer Cell Int. 2021. PMID: 34856989 Free PMC article. No abstract available.

2

Influence of Preoperative Serum Aspartate Aminotransferase (AST) Level on the Prognosis of Patients with Non-Small Cell Lung Cancer.

Chen SL, Xue N, Wu MT, Chen H, He X, Li JP, Liu WL, Dai SQ. Chen SL, et al. Among authors: chen h. Int J Mol Sci. 2016 Sep 3;17(9):1474. doi: 10.3390/ijms17091474. Int J Mol Sci. 2016. PMID: 27598151 Free PMC article.

3

High-dose Methotrexate plus temozolomide with or without rituximab in patients with untreated primary central nervous system lymphoma: A retrospective study from China.

Chen C, Sun P, Cui J, Yan S, Chen H, Xia Y, Bi X, Liu P, Wang Y, Yang H, Nie M, Zhang XW, Jiang W, Li ZM. Chen C, et al. Among authors: chen h. Cancer Med. 2019 Apr;8(4):1359-1367. doi: 10.1002/cam4.1906. Epub 2019 Mar 1. Cancer Med. 2019. PMID: 30821418 Free PMC article.

4

Dynamic serum biomarkers to predict the efficacy of PD-1 in patients with nasopharyngeal carcinoma.

Zhang A, Zhong G, Wang L, Cai R, Han R, Xu C, Chen S, Sun P, Chen H. Zhang A, et al. Among authors: chen s, chen h. Cancer Cell Int. 2021 Sep 28;21(1):518. doi: 10.1186/s12935-021-02217-y. Cancer Cell Int. 2021. PMID: 34583688 Free PMC article.

5

Establishment of using serum YKL-40 and SCCA in combination for the diagnosis of patients with esophageal squamous cell carcinoma.

Zheng X, Xing S, Liu XM, Liu W, Liu D, Chi PD, Chen H, Dai SQ, Zhong Q, Zeng MS, Liu WL. Zheng X, et al. Among authors: chen h. BMC Cancer. 2014 Jul 7;14:490. doi: 10.1186/1471-2407-14-490. BMC Cancer. 2014. PMID: 25001061 Free PMC article.

6

Nomogram Based on Liver Function Test Indicators for Survival Prediction in Nasopharyngeal Carcinoma Patients Receiving PD-1 Inhibitor Therapy.

Liang L, Li Y, Hong Y, Ji T, Chen H, Lin Z. Liang L, et al. Among authors: chen h. Curr Oncol. 2023 Jul 26;30(8):7189-7202. doi: 10.3390/curroncol30080521. Curr Oncol. 2023. PMID: 37623002 Free PMC article.

7

EA-D p45-IgG as a potential biomarker for nasopharyngeal carcinoma diagnosis.

Chen H, Luo YL, Zhang L, Tian LZ, Feng ZT, Liu WL. Chen H, et al. Asian Pac J Cancer Prev. 2013;14(12):7433-8. doi: 10.7314/apjcp.2013.14.12.7433. Asian Pac J Cancer Prev. 2013. PMID: 24460315 Free article.

8

[Assessment of detection assays of Epstein-Barr viral Rta-IgG, VCA-IgA, EA-IgA and Epstein-Barr viral DNA at different clinical stages in the diagnosis of nasopharyngeal carcinoma].

Luo YL, Chen H, Peng SG, Lin JH, Huang PY. Luo YL, et al. Among authors: chen h. Zhonghua Yi Xue Za Zhi. 2013 Nov 26;93(44):3516-9. Zhonghua Yi Xue Za Zhi. 2013. PMID: 24521892 Chinese.

9

Evaluation of a semi-quantitative ELISA for IgA antibody against Epstein-Barr virus capsid antigen in the serological diagnosis of nasopharyngeal carcinoma.

Chen H, Chi P, Wang W, Li L, Luo Y, Fu J, Zhang L, Liu W. Chen H, et al. Int J Infect Dis. 2014 Aug;25:110-5. doi: 10.1016/j.ijid.2014.03.1373. Epub 2014 May 27. Int J Infect Dis. 2014. PMID: 24878579 Free article.

10

Serum levels of soluble programmed death ligand 1 predict treatment response and progression free survival in multiple myeloma.

Wang L, Wang H, Chen H, Wang WD, Chen XQ, Geng QR, Xia ZJ, Lu Y. Wang L, et al. Among authors: chen xq, chen h. Oncotarget. 2015 Dec 1;6(38):41228-36. doi: 10.18632/oncotarget.5682. Oncotarget. 2015. PMID: 26515600 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

95,335 results

Search Page

Filters